Dixon Hubard Feinour & Brown Inc Portfolio Holdings

Dixon Hubard Feinour & Brown Inc

  • $842 Million
  • Q2 2022

Dixon Hubard Feinour & Brown Inc has filed its 13F form on July 22, 2022 for Q2 2022 where it was disclosed a total value porftolio of $842 Million distributed in 280 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apple Inc. with a value of $35.6M, Microsoft Corp with a value of $28.7M, Cme Group Inc. with a value of $19.4M, Vanguard with a value of $19M, and Adobe Inc. with a value of $15.6M.

Examining the 13F form we can see an decrease of $157M in the current position value, from $999M to 842M. Also it can be appreciated an additional of 8 stocks purchases and 36 closed positions.

Below you can find more details about Dixon Hubard Feinour & Brown Inc portfolio as well as his latest detailed transactions.

Portfolio value $842 Million
ETFs: $236 Million
Technology: $146 Million
Healthcare: $116 Million
Financial Services: $84.5 Million
Consumer Defensive: $57.6 Million
Industrials: $52.5 Million
Communication Services: $40 Million
Consumer Cyclical: $33.2 Million
Other: $73.9 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$23.1B
$237,000 0.03% of portfolio
7,146
Q2 2022 Added 5.0%
$148B
$253,000 0.03% of portfolio
4,001
Q2 2022 Reduced 40.71%
$0
$248,000 0.03% of portfolio
1,096
Q1 2022 Reduced 8.36%
$20.9B
$215,000 0.03% of portfolio
1,523
Q2 2022 Reduced 1.17%
$173B
$273,000 0.03% of portfolio
5,184
Q1 2022 New
$16.7B
$238,000 0.03% of portfolio
3,700
Q2 2022 Reduced 5.13%
$1.69B
$232,000 0.03% of portfolio
5,950
Q2 2022 Reduced 1.65%
$22.8B
$258,000 0.03% of portfolio
2,115
Q2 2022 New
$101B
$226,000 0.03% of portfolio
3,705
Q2 2022 Reduced 46.5%
$4.17B
$260,000 0.03% of portfolio
12,400
Q2 2022 Reduced 9.16%
$0
$240,000 0.03% of portfolio
2,363
Q2 2022 Reduced 0.96%
$9.58B
$216,000 0.03% of portfolio
1,240
Q1 2022 Reduced 12.8%
$0
$221,000 0.03% of portfolio
1,279
Q1 2022 Reduced 3.76%
$37.7B
$221,000 0.03% of portfolio
472
Q4 2021 New
$38.5B
$258,000 0.03% of portfolio
2,271
Q2 2022 Reduced 1.69%
$0
$253,000 0.03% of portfolio
1,662
Q2 2022 Added 12.22%
$141B
$276,000 0.03% of portfolio
3,030
Q2 2022 Reduced 20.47%
$0
$187,000 0.02% of portfolio
15,162
Q2 2022 Reduced 98.36%
$0
$186,000 0.02% of portfolio
14,873
Q4 2021 Added 25.51%
$0
$131,000 0.02% of portfolio
44,050
Q4 2021 Reduced 1.67%
$223B
$209,000 0.02% of portfolio
2,728
Q2 2022 Added 1.07%
$23.4B
$133,000 0.02% of portfolio
28,913
Q2 2022 Reduced 0.15%
$0
$70,000 0.01% of portfolio
11,200
Q3 2017 New
$187M
$115,000 0.01% of portfolio
85,873
Q2 2022 Reduced 1.94%
$5.66B
$57,000 0.01% of portfolio
13,219
Q2 2022 New
$53.8M
$65,000 0.01% of portfolio
11,229
Q2 2022 Reduced 0.88%
Therapeuticsmd Inc Com New
-
$0 0.0% of portfolio
-
Q2 2022 New
$4.09B
$27,000 0.0% of portfolio
15,000
Q2 2022 New

Summary

  • Portfolio
  • No. of Stocks 280
  • Current Value $842 Million
  • Prior Value $999 Million
  • Filing
  • Period Q2 2022
  • Filing Date July 22, 2022
  • Form Type 13F-HR
  • Activity in Q2 2022
  • New Purchases 8 stocks
  • Additional Purchases 70 stocks
  • Sold out of 36 stocks
  • Reduced holdings in 155 stocks
Track This Portfolio

Track Dixon Hubard Feinour & Brown Inc Portfolio

Follow Dixon Hubard Feinour & Brown Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email